DGAP-Ad-hoc: M1 Kliniken AG / Key word(s): Personnel/Miscellaneous 
M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. Promotion 
of the product business as core task of the integration of the Haemato Group 
into the M1 Kliniken AG - Group 
 
30-Nov-2020 / 15:30 CET/CEST 
Disclosure of an inside information acc. to Article 17 MAR of the Regulation 
(EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
*M1 Kliniken AG: Mr. Patrick Brenske joins the board of HAEMATO AG. 
Promotion of the product business as core task of the integration of the 
Haemato Group into the M1 Kliniken AG - Group* 
 
Berlin, 30.11.2020 - M1 Kliniken AG announces that as of today Mr. Patrick 
Brenske will join the Management Board of HAEMATO AG. At the same time, Mr. 
Brenske will resign from the Management Board of M1 Kliniken AG, with Dr. 
Walter von Horstig from now on acting as sole member of the Management 
Board. Mr. Brenske will continue to advise M1. 
 
Before joining M1 Kliniken AG, Mr. Patrick Brenske had already worked for 
the Haemato Group for about eight years as Head of Purchasing and Sales and 
led the group from a turnover in the small single-digit million range 
towards an annual turnover of close to 300 million euros. The attainment of 
the manufacturing licence in accordance with § 13 AMG (German medicines act) 
was one of the main drivers of HAEMATO's product business. 
 
After the acquisition of almost 50% of HAEMATO AG by M1 Kliniken AG by mid 
of 2020, M1 Kliniken AG follows the strategy of integrating the value chain 
and strengthening the product business. This offers potentials for added 
value - while ensuring quality. 
 
*About M1 Kliniken AG* 
 
M1 Kliniken AG is the leading provider of beauty medical health services in 
Germany. In the aesthetic and surgical field, the group offers products and 
services of the highest quality standards. Under the brand "M1 Med Beauty", 
beauty medical treatments are currently offered at more than 35 specialist 
centres. With six operating theatres and 35 beds, the M1 Schlossklinik für 
plastische und ästhetische Chirurgie in Berlin is one of the largest and 
most modern facilities of its kind in Europe. Since the end of 2018, M1 has 
been driving forward its internationalisation and is currently also active 
in Austria, Switzerland, the Netherlands, England and Australia. In 
addition, the Group markets high-quality products under the brands "M1 
Select" and "M1 Aesthetics" to private customers as well as doctors, 
pharmacies and wholesalers. 
 
Contact us: M1 Klinken AG 
Grünauer Strasse 5; D-12557 Berlin 
T: +49 (0) 30 34 74 74 - 414 
M: ir@m1-kliniken.de 
W: www.m1-kliniken.de 
 
30-Nov-2020 CET/CEST The DGAP Distribution Services include Regulatory 
Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
Language:    English 
Company:     M1 Kliniken AG 
             Grünauer Straße 5 
             12557 Berlin 
             Germany 
Phone:       +49 (0)30 347 47 44 14 
Fax:         +49 (0)30 347 47 44 17 
E-mail:      ir@m1-kliniken.de 
Internet:    https://www.m1-kliniken.de 
ISIN:        DE000A0STSQ8 
WKN:         A0STSQ 
Listed:      Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt 
             (Basic Board), Hamburg, Hanover, Munich, Stuttgart, Tradegate 
             Exchange 
EQS News ID: 1151538 
 
End of Announcement DGAP News Service 
 
1151538 30-Nov-2020 CET/CEST

(END) Dow Jones Newswires

November 30, 2020 09:30 ET (14:30 GMT)